alexa

GET THE APP

Percutaneous Ethanol Injection Treatment, Novel Solution for the Challenge of Recurrent Thyroid Pathology: A Review | OMICS International| Abstract
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Clin Exp Pathol 2014, Vol 4(3): 172
  • DOI: 10.4172/2161-0681.1000172

Percutaneous Ethanol Injection Treatment, Novel Solution for the Challenge of Recurrent Thyroid Pathology: A Review

Parisha Bhatia1, Tatyana E. Fontenot2, Koji Tsumagari1 and Emad Kandil1,2*
1Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA
2Department of Otolaryngology, Tulane University School of Medicine, New Orleans, LA, USA
*Corresponding Author : Emad Kandil, Department of Otolaryngology, Tulane Otolaryngology-Head & Neck Surgery, 1430 Tulane Avenue, SL 59, New Orleans, LA 70112, USA, Tel: 504-988-5454, Fax: 504-988-7846, Email: [email protected]

Received Date: Mar 22, 2014 / Accepted Date: Apr 26, 2014 / Published Date: Apr 28, 2014

Abstract

Introduction: Thyroid nodules are among the most common endocrine complaints in the United States. With increasing incidence of differentiated thyroid carcinoma there has been a widespread interest in development of minimally invasive treatments such as percutaneous ethanol injection (PEI) to manage thyroid pathology. In our review of published literatures, we discuss the application of ethanol injection for treatment of benign thyroid nodules and its efficacy in treating locally recurrent papillary thyroid carcinoma.
Evolving treatment roles of PEI: PEI has been most successful at treating recurrent cystic nodules. In hyperfunctioning nodules, PEI is indicated for patients who are poor surgical and radioiodine therapy candidates. Initial trials of PEI in metastatic lymph nodes in papillary thyroid carcinoma have yielded promising therapeutic results with only minor side effects. PEI does not remove the option of future radio-frequency ablation or surgery which may become necessary in some cases.
Conclusion: In our opinion, percutaneous ethanol injection proves to be a superior treatment modality for benign thyroid nodules showing markedly higher success in cystic nodules. Its safety and efficacy in treating recurrent papillary thyroid carcinoma is significant.

Keywords: Thyroid nodules, Recurrent thyroid carcinoma, Lymph node metastasis, Re-operation, Ethanol ablation

Citation: Bhatia P, Fontenot TE, Tsumagari K, Kandil E (2014) Percutaneous Ethanol Injection Treatment, Novel Solution for the Challenge of Recurrent Thyroid Pathology: A Review. J Clin Exp Pathol 4:172. Doi: 10.4172/2161-0681.1000172

Copyright: © 2014 Bhatia P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top